Evidence map›Paper›PMID 25118028›Full record

ReviewEuropean journal of human genetics : EJHG2015

Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature.

Merel Klaassens, Deborah Morrogh, Elisabeth M Rosser, Fatima Jaffer, Maaike Vreeburg, Levinus A Bok, Tim Segboer, Martine van Belzen, Ros M Quinlivan, Ajith Kumar and 2 more

Open access · bronzeAbstract readCase ReportsReview
In one paragraph

Review in European journal of human genetics : EJHG, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. NovelFrontiers in pediatrics · 2026
    Article
  3. Article
  4. [Nuclear Factor I-X Regulates Molecular Pathways Related to Craniofacial Development Through Phase Separation].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  5. Article
  6. Strabismus in Genetic Syndromes: A Review.Clinical & experimental ophthalmology · 2025
    Review
  7. Mechanistic insights intoFrontiers in genetics · 2025
    Article
  8. Article
  9. Article
  10. [Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2024
    Review
  11. Article
  12. Behavioral profiling in children and adolescents with Malan syndrome.Frontiers in child and adolescent psychiatry · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Case Report: Novel pathogenic variant inFrontiers in genetics · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Merel Klaassens1] Department of Paediatrics, Maastricht University Medical Center, Maastricht, The Netherlands [2] Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands [3] North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Deborah MorroghNorth East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Elisabeth M RosserNorth East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Fatima JafferMRC Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UK.
Maaike VreeburgDepartment of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
Levinus A BokDepartment of Paediatrics, Maxima Medical Centre, Belhaven, The Netherlands.
Tim SegboerDepartment of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Martine van BelzenDepartment of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Ros M QuinlivanMRC Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UK.
Ajith KumarNorth East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Jane A HurstNorth East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Richard H Scott1] North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, UK [2] Clinical and Molecular Genetics Unit, UCL Institute of Child Health, London, UK.
University College London · GBLeiden University · NLMaastricht University · NLNational Hospital for Neurology and Neurosurgery · GBRadboud University Nijmegen · NL

Funding

Department of HealthWellcome Trust 091986Wellcome Trust WT098051
6 · The paper itself

Abstract

De novo monoallelic variants in NFIX cause two distinct syndromes. Whole gene deletions, nonsense variants and missense variants affecting the DNA-binding domain have been seen in association with a Sotos-like phenotype that we propose is referred to as Malan syndrome. Frameshift and splice-site variants thought to avoid nonsense-mediated RNA decay have been seen in Marshall-Smith syndrome. We report six additional patients with Malan syndrome and de novo NFIX deletions or sequence variants and review the 20 patients now reported. The phenotype is characterised by moderate postnatal overgrowth and macrocephaly. Median height and head circumference in childhood are 2.0 and 2.3 standard deviations (SD) above the mean, respectively. There is overlap of the facial phenotype with NSD1-positive Sotos syndrome in some cases including a prominent forehead, high anterior hairline, downslanting palpebral fissures and prominent chin. Neonatal feeding difficulties and/or hypotonia have been reported in 30% of patients. Developmental delay/learning disability have been reported in all cases and are typically moderate. Ocular phenotypes are common, including strabismus (65%), nystagmus (25% ) and optic disc pallor/hypoplasia (25%). Other recurrent features include pectus excavatum (40%) and scoliosis (25%). Eight reported patients have a deletion also encompassing CACNA1A, haploinsufficiency of which causes episodic ataxia type 2 or familial hemiplegic migraine. One previous case had episodic ataxia and one case we report has had cyclical vomiting responsive to pizotifen. In individuals with this contiguous gene deletion syndrome, awareness of possible later neurological manifestations is important, although their penetrance is not yet clear.

Indexed as

Genetic Association StudiesMutationPhenotypeSequence DeletionChild, PreschoolComparative Genomic HybridizationDiagnosis, DifferentialFaciesFemaleHumansInfantMaleNFI Transcription FactorsSotos SyndromeSyndromeNFI Transcription FactorsNFIX protein, human

Identifiers

PMID25118028
PMCPMC4402637
OpenAlexW2068211965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.